Jessica Woelfel - Sep 29, 2025 Form 4 Insider Report for ORMAT TECHNOLOGIES, INC. (ORA)

Role
GC, CCO, and CS
Signature
/s/ Jessica Woelfel
Stock symbol
ORA
Transactions as of
Sep 29, 2025
Transactions value $
-$531,369
Form type
4
Date filed
9/30/2025, 09:57 PM
Previous filing
Aug 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Woelfel Jessica GC, CCO, and CS C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO /s/ Jessica Woelfel 2025-09-30 0001909177

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORA Common Stock Options Exercise $503K +6.4K +122.3% $78.53 11.6K Sep 29, 2025 Direct F1
transaction ORA Common Stock Disposed to Issuer -$503K -5.29K -45.47% $95.00 6.34K Sep 29, 2025 Direct F2
transaction ORA Common Stock Options Exercise $691K +10K +191.06% $69.14 15.2K Sep 29, 2025 Direct F3
transaction ORA Common Stock Disposed to Issuer -$691K -7.3K -47.92% $94.64 7.93K Sep 29, 2025 Direct F4
transaction ORA Common Stock Sale -$532K -5.61K -62.04% $94.80 3.43K Sep 29, 2025 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORA Stock Appreciation Rights (SARs) Options Exercise $0 -6.4K -100% $0.00 0 Sep 29, 2025 Common Stock 6.4K $78.53 Direct
transaction ORA Stock Appreciation Rights (SARs) Options Exercise $0 -10K -100% $0.00 0 Sep 29, 2025 Common Stock 10K $69.14 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the exercise of Stock Appreciation Rights ("SARs") expiring on March 31, 2027, for which the reporting person exercised all 6,401 shares.
F2 This represents the difference between the number of SARs exercised (6,401) and the number of shares issued as a result of the exercise (1,110) The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($95.00) and the exercise price ($78.53).
F3 Represents the exercise of SARs expiring on June 15, 2026, for which the reporting person exercised all 10,000 shares.
F4 This represents the difference between the number of SARs exercised (10,000) and the number of shares issued as a result of the exercise (2,700). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($94.64) and the exercise price ($69.14).
F5 Represents shares of common stock sold in the open market on September 29, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025.
F6 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.36 to $95.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein.